The clinical importance of plasma substitutes.
D000758:Anesthesia / Q000009:adverse effects; D001787:Blood Group Incompatibility / Q000209:etiology / Q000517:prevention & control; D003681:Dehydration / Q000139:chemically induced; D003911:Dextrans / Q000009:adverse effects / Q000627:therapeutic use; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D005780:Gelatin / Q000627:therapeutic use; D006323:Heart Arrest / Q000209:etiology; D006801:Humans; D008107:Liver Diseases / Q000517:prevention & control; D008297:Male; D008353:Mannitol / Q000627:therapeutic use; D008970:Molecular Weight; D010952:Plasma Substitutes / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control*; D011188:Potassium / Q000097:blood; D012151:Resuscitation; D012771:Shock, Hemorrhagic / Q000517:prevention & control*; D012773:Shock, Surgical; D013514:Surgical Procedures, Operative; D065227:Transfusion Reaction
D003911:Dextrans; D010952:Plasma Substitutes; D008353:Mannitol; D005780:Gelatin; D011188:Potassium